Observational study reveals elevated plasma miR-92 levels in colorectal cancer patients, indicating its potential as a non-invasive screening biomarker.
MiR-92 is significantly elevated in plasma of patients with CRC and can be a potential non-invasive molecular marker for CRC screening.
No takes yet. Share an insight, caveat, or question.
Ng et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: